Effect of statins on survival following stroke in patients with cancer

Ye Sel Kim, Moo Seok Park, Jun Hwa Lee, Jong Won Chung, Mi Ji Lee, Chi Kyung Kim, Jin-Man Jung, Kyungmi Oh, Oh Young Bang, Geong Moon Kim, Ji Mi Choi, Juneyoung Lee, Chin Sang Chung, Kwang Ho Lee, Woo Keun Seo

Research output: Contribution to journalArticle

Abstract

The objective of this study was to investigate the potential benefits of statin therapy initiation in acute stroke in patients with active cancer. This study was conducted in two parts. First, data from patients who are presented with stroke and active cancer were obtained from prospectively collected multicenter hospital-based stroke registries. Patients were classified into statin user and non-user groups; the statin group was further divided into low-potency and high-potency statin subgroups. The primary outcome was time to mortality. Second, we obtained data from the Korean National Health Information Service-National Sample Cohort (NHIS-NSC) database for external validation and analyzed the effect of statins on mortality, taking compliance into consideration. For the stroke registry cohort, statin use was independently associated with reduced mortality in a multivariable model [hazard ratio (HR) = 0.675, 95% confidence interval (CI) = 0.457-0.996]. There was no interaction between statin use and cancer characteristics, vascular risk factors, or laboratory findings. A dose-dependent relationship between statin use and survival was also demonstrated. Analysis of the NHIS-NSC database found a similar association between statin therapy and reduced mortality (adjusted HR = 0.64, 95% CI = 0.45-0.90) and this effect persisted even after controlling for the adherence of statin use (HR = 0.60, 95% CI = 0.41-0.89). Statin therapy could be associated with reduced mortality in patients with acute stroke and active cancer.

Original languageEnglish
Article number205
JournalFrontiers in Neurology
Volume9
Issue numberAPR
DOIs
Publication statusPublished - 2018 Apr 24

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Stroke
Survival
Neoplasms
Mortality
Information Services
National Health Programs
Confidence Intervals
Registries
Databases
Proportional Hazards Models
Compliance
Therapeutics

Keywords

  • Cancer
  • Mortality
  • Outcome
  • Statin
  • Stroke

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Kim, Y. S., Park, M. S., Lee, J. H., Chung, J. W., Lee, M. J., Kim, C. K., ... Seo, W. K. (2018). Effect of statins on survival following stroke in patients with cancer. Frontiers in Neurology, 9(APR), [205]. https://doi.org/10.3389/fneur.2018.00205

Effect of statins on survival following stroke in patients with cancer. / Kim, Ye Sel; Park, Moo Seok; Lee, Jun Hwa; Chung, Jong Won; Lee, Mi Ji; Kim, Chi Kyung; Jung, Jin-Man; Oh, Kyungmi; Bang, Oh Young; Kim, Geong Moon; Choi, Ji Mi; Lee, Juneyoung; Chung, Chin Sang; Lee, Kwang Ho; Seo, Woo Keun.

In: Frontiers in Neurology, Vol. 9, No. APR, 205, 24.04.2018.

Research output: Contribution to journalArticle

Kim, YS, Park, MS, Lee, JH, Chung, JW, Lee, MJ, Kim, CK, Jung, J-M, Oh, K, Bang, OY, Kim, GM, Choi, JM, Lee, J, Chung, CS, Lee, KH & Seo, WK 2018, 'Effect of statins on survival following stroke in patients with cancer', Frontiers in Neurology, vol. 9, no. APR, 205. https://doi.org/10.3389/fneur.2018.00205
Kim, Ye Sel ; Park, Moo Seok ; Lee, Jun Hwa ; Chung, Jong Won ; Lee, Mi Ji ; Kim, Chi Kyung ; Jung, Jin-Man ; Oh, Kyungmi ; Bang, Oh Young ; Kim, Geong Moon ; Choi, Ji Mi ; Lee, Juneyoung ; Chung, Chin Sang ; Lee, Kwang Ho ; Seo, Woo Keun. / Effect of statins on survival following stroke in patients with cancer. In: Frontiers in Neurology. 2018 ; Vol. 9, No. APR.
@article{bd387c9f2dc1410a903cbfa3b862b11c,
title = "Effect of statins on survival following stroke in patients with cancer",
abstract = "The objective of this study was to investigate the potential benefits of statin therapy initiation in acute stroke in patients with active cancer. This study was conducted in two parts. First, data from patients who are presented with stroke and active cancer were obtained from prospectively collected multicenter hospital-based stroke registries. Patients were classified into statin user and non-user groups; the statin group was further divided into low-potency and high-potency statin subgroups. The primary outcome was time to mortality. Second, we obtained data from the Korean National Health Information Service-National Sample Cohort (NHIS-NSC) database for external validation and analyzed the effect of statins on mortality, taking compliance into consideration. For the stroke registry cohort, statin use was independently associated with reduced mortality in a multivariable model [hazard ratio (HR) = 0.675, 95{\%} confidence interval (CI) = 0.457-0.996]. There was no interaction between statin use and cancer characteristics, vascular risk factors, or laboratory findings. A dose-dependent relationship between statin use and survival was also demonstrated. Analysis of the NHIS-NSC database found a similar association between statin therapy and reduced mortality (adjusted HR = 0.64, 95{\%} CI = 0.45-0.90) and this effect persisted even after controlling for the adherence of statin use (HR = 0.60, 95{\%} CI = 0.41-0.89). Statin therapy could be associated with reduced mortality in patients with acute stroke and active cancer.",
keywords = "Cancer, Mortality, Outcome, Statin, Stroke",
author = "Kim, {Ye Sel} and Park, {Moo Seok} and Lee, {Jun Hwa} and Chung, {Jong Won} and Lee, {Mi Ji} and Kim, {Chi Kyung} and Jin-Man Jung and Kyungmi Oh and Bang, {Oh Young} and Kim, {Geong Moon} and Choi, {Ji Mi} and Juneyoung Lee and Chung, {Chin Sang} and Lee, {Kwang Ho} and Seo, {Woo Keun}",
year = "2018",
month = "4",
day = "24",
doi = "10.3389/fneur.2018.00205",
language = "English",
volume = "9",
journal = "Frontiers in Neurology",
issn = "1664-2295",
publisher = "Frontiers Research Foundation",
number = "APR",

}

TY - JOUR

T1 - Effect of statins on survival following stroke in patients with cancer

AU - Kim, Ye Sel

AU - Park, Moo Seok

AU - Lee, Jun Hwa

AU - Chung, Jong Won

AU - Lee, Mi Ji

AU - Kim, Chi Kyung

AU - Jung, Jin-Man

AU - Oh, Kyungmi

AU - Bang, Oh Young

AU - Kim, Geong Moon

AU - Choi, Ji Mi

AU - Lee, Juneyoung

AU - Chung, Chin Sang

AU - Lee, Kwang Ho

AU - Seo, Woo Keun

PY - 2018/4/24

Y1 - 2018/4/24

N2 - The objective of this study was to investigate the potential benefits of statin therapy initiation in acute stroke in patients with active cancer. This study was conducted in two parts. First, data from patients who are presented with stroke and active cancer were obtained from prospectively collected multicenter hospital-based stroke registries. Patients were classified into statin user and non-user groups; the statin group was further divided into low-potency and high-potency statin subgroups. The primary outcome was time to mortality. Second, we obtained data from the Korean National Health Information Service-National Sample Cohort (NHIS-NSC) database for external validation and analyzed the effect of statins on mortality, taking compliance into consideration. For the stroke registry cohort, statin use was independently associated with reduced mortality in a multivariable model [hazard ratio (HR) = 0.675, 95% confidence interval (CI) = 0.457-0.996]. There was no interaction between statin use and cancer characteristics, vascular risk factors, or laboratory findings. A dose-dependent relationship between statin use and survival was also demonstrated. Analysis of the NHIS-NSC database found a similar association between statin therapy and reduced mortality (adjusted HR = 0.64, 95% CI = 0.45-0.90) and this effect persisted even after controlling for the adherence of statin use (HR = 0.60, 95% CI = 0.41-0.89). Statin therapy could be associated with reduced mortality in patients with acute stroke and active cancer.

AB - The objective of this study was to investigate the potential benefits of statin therapy initiation in acute stroke in patients with active cancer. This study was conducted in two parts. First, data from patients who are presented with stroke and active cancer were obtained from prospectively collected multicenter hospital-based stroke registries. Patients were classified into statin user and non-user groups; the statin group was further divided into low-potency and high-potency statin subgroups. The primary outcome was time to mortality. Second, we obtained data from the Korean National Health Information Service-National Sample Cohort (NHIS-NSC) database for external validation and analyzed the effect of statins on mortality, taking compliance into consideration. For the stroke registry cohort, statin use was independently associated with reduced mortality in a multivariable model [hazard ratio (HR) = 0.675, 95% confidence interval (CI) = 0.457-0.996]. There was no interaction between statin use and cancer characteristics, vascular risk factors, or laboratory findings. A dose-dependent relationship between statin use and survival was also demonstrated. Analysis of the NHIS-NSC database found a similar association between statin therapy and reduced mortality (adjusted HR = 0.64, 95% CI = 0.45-0.90) and this effect persisted even after controlling for the adherence of statin use (HR = 0.60, 95% CI = 0.41-0.89). Statin therapy could be associated with reduced mortality in patients with acute stroke and active cancer.

KW - Cancer

KW - Mortality

KW - Outcome

KW - Statin

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=85046672976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046672976&partnerID=8YFLogxK

U2 - 10.3389/fneur.2018.00205

DO - 10.3389/fneur.2018.00205

M3 - Article

AN - SCOPUS:85046672976

VL - 9

JO - Frontiers in Neurology

JF - Frontiers in Neurology

SN - 1664-2295

IS - APR

M1 - 205

ER -